Drug Profile
Research programme: HIV integrase inhibitors - Bristol-Myers Squibb
Alternative Names: BMS-707035; BMS-727740Latest Information Update: 15 Jul 2015
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class 2 ring heterocyclic compounds; Antivirals; Oxazines; Pyrimidines; Triazoles
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections